Bosch expands pharma solid seminar range
Practical trainings on globally trending topics.
Bosch Packaging Technology has expanded its range of seminars for the development and production of solid pharmaceuticals under the umbrella of the Bosch Packaging Academy. In response to an increasing demand, Bosch now offers more practical trainings on sought-after topics, for instance at the German sites in Schopfheim and Waiblingen.
Learning from industry experts
The lectures are given by Bosch associates from different departments together with external industry and research experts. Participants benefit from a mix of theoretical industry knowledge, long-term experience and practical training in the local laboratories. "Our goal is to consistently adapt the trainings to participants' needs," explains Dr Marcus Knöll, head of the pharma service department of the Bosch subsidiary Hüttlin GmbH in Schopfheim. "Due to keen interest, we have continuously expanded our range of seminars over the years. And most of them are fully booked within a very short time."
In 2016, the Schopfheim site offers specific operator trainings for granulation and fluid bed usage, as well as seminars focusing on scale-up, granulation and coating. In the scale-up seminar, for instance, lecturers provide a deeper insight into the possibilities of scale-up. "Our specialists train the participants regarding the ideal approach and explain all practical process steps in detail," says Dr Knöll.
Seminars on capsules and tablets
The site in Waiblingen, Germany, offers several capsule school workshops. The seminar series provides information about the production and pharmaceutical application of hard capsules, the development of formulations, as well as different filling technologies. Further seminars from Bosch include processes, current trends and developments in tablet pressing and coating for different therapeutic areas.
The structure of the seminars offers flexible possibilities to obtain the title "Specialist of Operation", "Expert of Solid", or “Master of Solid”. In addition to the seminar certificate, the competence centers award credit points in three different categories. Depending on the difficulty level, participants receive one, two or three credit points per completed training course.
Seminar schedule 2016 at a glance
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance